Published in J Virol on July 01, 1993
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
One retroviral RNA is sufficient for synthesis of viral DNA. J Virol (1994) 1.60
Evolution and horizontal transfer of dUTPase-encoding genes in viruses and their hosts. J Virol (1999) 1.41
Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol (1995) 1.31
Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res (1994) 1.30
Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. J Virol (2001) 1.14
Recombination creates novel L1 (LINE-1) elements in Rattus norvegicus. Genetics (1997) 1.13
Packaging and reverse transcription of snRNAs by retroviruses may generate pseudogenes. RNA (2004) 1.10
RNA-RNA recombination in Sindbis virus: roles of the 3' conserved motif, poly(A) tail, and nonviral sequences of template RNAs in polymerase recognition and template switching. J Virol (1997) 1.07
Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses. J Virol (2004) 1.05
Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles. Nucleic Acids Res (2007) 0.99
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
Copackaging of different-sized retroviral genomic RNAs: little effect on retroviral replication or recombination. J Virol (1994) 0.82
Acutely transforming retrovirus expressing Nras generated from HT-1080 fibrosarcoma cells infected with the human retrovirus XMRV. J Virol (2010) 0.81
Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology (2006) 0.81
Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination. J Virol (2007) 0.80
DNA integration by Ty integrase in yku70 mutant Saccharomyces cerevisiae cells. Mol Cell Biol (2000) 0.80
Characterization of a unique retroviral recombinant containing 7S L sequences. J Virol (1993) 0.77
The recombination rate is not increased when retroviral RNA is missing an encapsidation sequence. J Virol (1996) 0.76
The Host RNAs in Retroviral Particles. Viruses (2016) 0.76
LTR-mediated retroposition as a mechanism of RNA-based duplication in metazoans. Genome Res (2016) 0.76
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69
Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell (1983) 7.37
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol (1987) 6.88
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Retroviral recombination and reverse transcription. Science (1990) 6.27
Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell (1982) 6.19
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell (1980) 5.68
An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization. Cell (1978) 4.66
Nucleotide sequence of Fujinami sarcoma virus: evolutionary relationship of its transforming gene with transforming genes of other sarcoma viruses. Cell (1982) 4.06
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A (1983) 3.41
cis-Acting RNA packaging locus in the 115-nucleotide direct repeat of Rous sarcoma virus. J Virol (1983) 3.34
Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination. J Virol (1981) 2.53
Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs. J Virol (1993) 2.52
Conserved arrangement of nested genes at the Drosophila Gart locus. Genetics (1987) 2.37
Mechanism of transduction by retroviruses. Science (1992) 2.37
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
Creation of a processed pseudogene by retroviral infection. Cell (1987) 2.30
Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol (1992) 2.29
Specificity of retroviral RNA packaging. J Virol (1991) 2.22
Retroviral recombination during reverse transcription. Proc Natl Acad Sci U S A (1990) 2.17
Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences. J Virol (1985) 1.90
Structure of a cloned circular retroviral DNA containing a tRNA sequence between the terminal repeats. J Virol (1986) 1.72
Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction. Science (1987) 1.65
Effect of gamma radiation on retroviral recombination. J Virol (1992) 1.43
The role of RNA molecules in transduction of the proto-oncogene c-fps. Cell (1986) 1.39
Nucleotide sequence and topography of chicken c-fps. Genesis of a retroviral oncogene encoding a tyrosine-specific protein kinase. J Mol Biol (1985) 1.35
Reverse transcription of 7S L RNA by an avian retrovirus. J Virol (1985) 1.34
Unusual features of integrated cDNAs generated by infection with genome-free retroviruses. Mol Cell Biol (1990) 1.32
Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants. J Virol (1990) 1.31
High-frequency recombination within the gag gene of Rous sarcoma virus. J Virol (1979) 1.30
Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines. Proc Natl Acad Sci U S A (1985) 1.23
Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA. Proc Natl Acad Sci U S A (1988) 1.17
Transduction of cellular neo mRNA by retrovirus-mediated recombination. J Virol (1990) 1.08
Evidence that retroviral transduction is mediated by DNA not by RNA. Proc Natl Acad Sci U S A (1990) 1.02
Nucleotide sequence of v-fps in the PRCII strain of avian sarcoma virus. J Virol (1984) 0.97
Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts. J Virol (1992) 0.93
Common mechanism of retrovirus activation and transduction of c-mil and c-Rmil in chicken neuroretina cells infected with Rous-associated virus type 1. J Virol (1991) 0.83
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science (1996) 3.25
Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs. J Virol (1993) 2.52
Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal. J Virol (1994) 2.21
Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol (1993) 2.18
Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev (2001) 2.08
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol (1996) 1.91
Evidence that the human foamy virus genome is DNA. J Virol (1999) 1.85
The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol (1998) 1.82
Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J Biol Chem (1996) 1.46
Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol (2001) 1.38
Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence. J Virol (1996) 1.36
Unusual features of integrated cDNAs generated by infection with genome-free retroviruses. Mol Cell Biol (1990) 1.32
Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol (1995) 1.31
Foamy virus infection in primates. J Med Primatol (2006) 1.23
Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol (2006) 1.23
The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology (1995) 1.23
A minimal avian retroviral packaging sequence has a complex structure. J Virol (1998) 1.20
Proteolytic activity, the carboxy terminus of Gag, and the primer binding site are not required for Pol incorporation into foamy virus particles. J Virol (1999) 1.18
Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol (2000) 1.14
Secondary structure analysis of a minimal avian leukosis-sarcoma virus packaging signal. J Virol (2000) 1.12
Productive persistent infection of hematopoietic cells by human foamy virus. J Virol (1996) 1.12
Molecular cloning and characterization of the RNA packaging-defective retrovirus SE21Q1b. J Virol (1992) 1.09
An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles. J Virol (1999) 1.07
Tissue-specific lability and expression of avian leukosis virus long terminal repeat enhancer-binding proteins. Mol Cell Biol (1989) 1.05
Cell-type-specific regulation of the two foamy virus promoters. J Virol (2001) 1.00
The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays. J Virol (1999) 0.99
The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors. J Virol (1995) 0.97
gag as well as myc sequences contribute to the transforming phenotype of the avian retrovirus FH3. J Virol (1992) 0.92
Endogenous virus of BHK-21 cells complicates electron microscopy studies of foamy virus maturation. J Virol (1999) 0.89
FH3, a v-myc avian retrovirus with limited transforming ability. J Virol (1989) 0.88
Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection. J Virol (1993) 0.87
Transforming ability of Gag-Myc fusion proteins correlates with Gag-Myc protein stability and transcriptional repression. Oncogene (2001) 0.87
Yeast three-hybrid screening of rous sarcoma virus mutants with randomly mutagenized minimal packaging signals reveals regions important for gag interactions. J Virol (2000) 0.86
Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol Cell Biol (1993) 0.85
Retrotransposition of nonviral RNAs in an avian packaging cell line. J Virol (1998) 0.77
Characterization of a unique retroviral recombinant containing 7S L sequences. J Virol (1993) 0.77
v-Myc is invariably required to sustain rapid proliferation of infected cells but in stable cell lines becomes dispensable for other traits of the transformed phenotype. Oncogene (1995) 0.77
Tail-to-head arrangement of a partial chicken glyceraldehyde-3-phosphate dehydrogenase processed pseudogene. J Mol Evol (1997) 0.77
Inhibition of wild-type HIV-1 virus production by a matrix deficient Gag mutant. Virology (1995) 0.75